InvestorsHub Logo
Followers 59
Posts 18522
Boards Moderated 0
Alias Born 11/29/2006

Re: None

Monday, 09/14/2020 7:15:12 AM

Monday, September 14, 2020 7:15:12 AM

Post# of 789
New Results Evaluating Combination of VS-6766 and Defactinib to be Presented at the 2nd Annual RAS-Targeted Drug Development Summit

Management to Host Investor Conference Call and Webcast on Wednesday, September 16 at 8:00 AM ET
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VSTM News